Interview with the World Class Authorities Frontiers of Cancer Research: An exclusive interview with Professor Luis Diaz
Annals of Gastroenterological Surgery · 2025-05 · 9 (3) · 401-407
DOI: 10.1002/ags3.70003 ↗Kurz gefasst
Fachartikel in der Zeitschrift Annals of Gastroenterological Surgery, online erschienen am 03.03.2025. Verfasst von Haruna Takeda und 4 weiteren Autor:innen. Beteiligte Einrichtung: The Laboratory of Molecular Genetics National Cancer Center Research Institute Tokyo Japan. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 13 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
This manuscript provides an in‐depth interview with Prof. Luis Diaz, Head of Oncology at Memorial Sloan Kettering Cancer Center and Editor‐in‐Chief of Cancer Discovery . A globally recognized leader in oncology, Prof. Diaz discusses the transformative impact of precision oncology, particularly the role of mismatch repair deficiency (dMMR) and microsatellite instability‐high (MSI‐H) biomarkers in immunotherapy. He highlights the groundbreaking success of PD‐1 blockade therapies, such as dostarlimab, which have achieved unprecedented complete response rates in dMMR/MSI‐H rectal cancer, emphasizing its tumor‐agnostic potential. Prof. Diaz reflects on the evolution of cancer diagnostics, notably circulating tumor DNA (ctDNA) for minimal residual disease (MRD) detection, and its implications for treatment personalization and early detection. He also addresses the challenges and prospects of cancer prevention, advocating for innovative approaches such as immunoprevention and vaccines targeting tumor‐specific pathways, like the HPV vaccine for cervical cancer. The interview underscores the importance of fundamental research in advancing cancer care and the necessity of interdisciplinary collaboration to address unresolved questions in tumor biology. By sharing his vision and pioneering achievements, Prof. Diaz inspires the next generation of clinicians and researchers to pursue bold innovations, ultimately aiming to enhance patient outcomes and revolutionize the future of oncology. This dialogue serves as a significant resource for understanding current trends and future directions in cancer research and treatment.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- The Laboratory of Molecular Genetics National Cancer Center Research Institute Tokyo Japan.
- Department of Surgery Kyushu University Beppu Hospital Beppu Japan.
- WPI Nano-Life Science Institute (Nano-LSI) Kanazawa University Kanazawa Japan.
- Division of Genetics, Cancer Research Institute Kanazawa University Kanazawa Japan.
- Department of General Surgical Science, Graduate School of Medicine Gunma University Maebashi Japan.
- Department of Surgery Keio University School of Medicine Tokyo Japan.
ORCID-Profile: Koshi Mimori
Zitieren
APA
Takeda, H., Mimori, K., Oshima, M., Shirabe, K., & Kitagawa, Y. (2025). Interview with the World Class Authorities Frontiers of Cancer Research: An exclusive interview with Professor Luis Diaz. Annals of Gastroenterological Surgery, 9(3), 401-407. https://doi.org/10.1002/ags3.70003
Vancouver
Takeda H, Mimori K, Oshima M, Shirabe K, Kitagawa Y. Interview with the World Class Authorities Frontiers of Cancer Research: An exclusive interview with Professor Luis Diaz. Annals of Gastroenterological Surgery. 2025;9(3):401-407. doi:10.1002/ags3.70003
BibTeX
@article{Takeda2025,
author = {Takeda, Haruna and Mimori, Koshi and Oshima, Masanobu and Shirabe, Ken and Kitagawa, Yuko},
title = {Interview with the World Class Authorities Frontiers of Cancer Research: An exclusive interview with Professor Luis Diaz},
journal = {Annals of Gastroenterological Surgery},
year = {2025},
volume = {9},
number = {3},
pages = {401--407},
doi = {10.1002/ags3.70003}
}
EUVIMED